文献速递乳腺病理

乳腺癌空心针活检与细针穿刺活检后5至15年远处转移率的比较

Core-needle biopsy of breast cancer is associated with a higher rate of distant metastases 5 to 15 years after diagnosis than FNA biopsy.
PubMed 文献 · Cancer Cytopathol · 2017-08-24

该研究比较了20世纪70年代采用细针穿刺活检(FNAB)与90年代采用空心针活检(CNB)诊断的乳腺癌患者的长期结局。经严格匹配后随访15年发现,CNB诊断患者出现晚期(诊断后5-15年)远处转移的比率显著高于FNAB诊断患者,而两组局部转移无显著差异。

要点

  • CNB诊断的乳腺癌患者5-15年远处转移率显著高于FNAB诊断者。
  • 两种活检方式诊断后的局部转移率无显著差异。
  • 需关注诊断性活检方式对乳腺癌长期远处转移的潜在影响。

核心结论

  • 乳腺癌诊断后5至15年,CNB诊断患者远处转移率显著高于FNAB诊断患者。

研究设计与样本

  • 比较1971-1976年FNAB诊断(n=354)与1991-1995年CNB诊断(n=1729)的乳腺癌患者临床结局。
  • 调整治疗方式、钼靶筛查、肿瘤大小、DNA倍体及年龄差异后,选取严格匹配样本FNAB组(n=181)和CNB组(n=203)进行15年随访。

主要发现

  • 严格匹配组比较显示,CNB诊断患者诊断后5-15年出现的远处转移率显著高于FNAB诊断患者。
  • 两组局部转移率无显著差异。

临床怎么用

  • 在乳腺癌诊断选择活检方式时,应综合考虑CNB与FNAB在长期远处转移风险上的潜在差异。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The literature offers discordant results regarding whether diagnostic biopsy is associated with the dissemination of cancer cells, resulting in local and/or distant metastasis. The long-term outcomes of patients with breast cancer were compared between those who were diagnosed using either fine-needle aspiration biopsy (FNAB) or core-needle biopsy (CNB) during 2 decades: the 1970s and 1990s. METHODS: In the 1970s, the only diagnostic needle biopsy method used for breast cancer in Sweden was FNAB. CNB was introduced 1989 and became established in Stockholm Gotland County in the early 1990s. The authors compared the clinical outcomes of patients diagnosed using FNAB from 1971 to 1976 (n = 354) versus those of patients diagnosed using CNB from 1991 to 1995 (n = 1729). Adjusting for differences in various treatment modalities, mammography screening, tumor size, DNA ploidy, and patient age between the 2 decades, 2 strictly matched samples representing FNAB (n = 181) and CNB (n = 203) were selected for a 15-year follow-up study. RESULTS: In a comparison of the rates of distant metastasis in the strictly matched patient groups from the FNAB and CNB cohorts, significantly higher rates of late-appearing (5-15 years after diagnosis) distant metastasis were observed among the patients who were diagnosed on CNB compared with those who were diagnosed on FNAB. No significant difference in local metastasis was observed between the 2 groups. CONCLUSIONS: At 5 to 15 years after diagnosis of the primary tumor, CNB-diagnosed patients had significantly higher rates of distant metastases than FNAB-diagnosed patients. Cancer Cytopathol 2017;125:748-56. © 2017 American Cancer Society.

来源:Cancer Cytopathol,查看原文。版权归原作者所有。

引用

  1. Sennerstam RB, Franzén BSH, Wiksell HOT, et al. Core-needle biopsy of breast cancer is associated with a higher rate of distant metastases 5 to 15 years after diagnosis than FNA biopsy. Cancer Cytopathol. 2017. PMID: 28837268. doi:10.1002/cncy.21909

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。